Related Experiment Video
Updated: Jul 11, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient
Paula I Moreira1, Peggy L R Harris, Xiongwei Zhu
1Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
Lipoic acid (LA) and N-acetyl cysteine (NAC) antioxidants protect Alzheimer disease (AD) fibroblasts from oxidative stress and apoptosis. Combining LA and NAC offers greater protection, suggesting mitochondrial dysfunction is key in AD pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alzheimer disease (AD) is characterized by increased oxidative stress and apoptosis.
- Mitochondrial dysfunction is implicated in the pathogenesis of AD.
Purpose of the Study:
- To evaluate the protective effects of lipoic acid (LA) and N-acetyl cysteine (NAC) on oxidative and apoptotic markers in AD fibroblasts.
- To investigate the role of mitochondrial dysfunction in AD-related oxidative damage.
Main Methods:
- Fibroblast cultures from AD patients and controls were treated with LA and NAC.
- Oxidative stress markers (4-HNE, CML, HO-1) and apoptotic markers (caspase 9, Bax) were measured.
- Mitochondrial dysfunction was induced using N-methylprotoporphyrin.
Main Results:
- AD fibroblasts exhibited elevated oxidative and apoptotic markers.
- LA and NAC treatment reduced these markers, with combined treatment showing enhanced efficacy.
- N-methylprotoporphyrin induced AD-like changes, which were reversed by LA and NAC.
Conclusions:
- Mitochondrial dysfunction contributes significantly to oxidative damage in AD.
- Antioxidant therapy with LA and NAC shows promise for managing AD-related oxidative stress.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Alzheimer's Disease: Treatment
Mitochondria
Alzheimer Disease ll: Pathophysiology
